Tradestie Institutional Equity Comparison Engine
NURE vs HAUS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NURE Overall Edge
NURE Captures Institutional Edge (1โ0 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nuveen Short-Term REIT ETF (NURE) driven by superior Momentum & Technical. Fundamentally, NURE trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HAUS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, NURE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HAUS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NURE N/M vs HAUS N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
NURE
1Y +14.6% vs +3.4% ยท 52W Pos 72% vs 50%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NURE
Cboe BZX
Nuveen Short-Term REIT ETF
Institutional Equity
$31.59
-0.35% 1D
Market Cap
N/A
1M Return
-0.29%
1Y Return
+14.55%
Forward P/E
N/M
Unified AI Score
47.9 / 100
HOLD
Tech 48.0
Fund 38.0
Flow 50.0
Mom 25.9
HAUS
Cboe BZX
Residential REIT ETF
Institutional Equity
$17.75
+0.78% 1D
Market Cap
N/A
1M Return
+5.29%
1Y Return
+3.38%
Forward P/E
N/M
Unified AI Score
40.0 / 100
SELL
Tech 40.0
Fund 47.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NURE +14.55%
HAUS +3.38%
Spread: +15.83 pp (NURE Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NURE TTM Op. Margin: N/A
HAUS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NURE vs HAUS. Trailing 12-month operating profitability (NURE N/A vs HAUS N/A) and valuation multiples (NURE N/M vs HAUS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NURE | HAUS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 72% ($27โ$33) | 50% ($16โ$20) | Stronger Trend | NURE |
| Beta / 30D Volatility Risk Regime | 0.25ฮฒ ยท 17% Vol | 0.15ฮฒ ยท 22% Vol | Lower Realized Risk | NURE |
| Unified Institutional Score Composite Signal | 47.9 / 100 (HOLD) | 40.0 / 100 (SELL) | Higher Composite | NURE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NURE vs HAUS Buy Guide
NURE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
HAUS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NURE nor HAUS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.